177 related articles for article (PubMed ID: 22973058)
1. 8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers.
Polotskaia A; Hoffman S; Krett NL; Shanmugam M; Rosen ST; Bargonetti J
Mol Cancer Ther; 2012 Nov; 11(11):2495-504. PubMed ID: 22973058
[TBL] [Abstract][Full Text] [Related]
2. 8-Chloro-Adenosine Inhibits Proliferation of MDA-MB-231 and SK-BR-3 Breast Cancer Cells by Regulating ADAR1/p53 Signaling Pathway.
Ding HY; Yang WY; Zhang LH; Li L; Xie F; Li HY; Chen XY; Tu Z; Li Y; Chen Y; Yang SY
Cell Transplant; 2020; 29():963689720958656. PubMed ID: 32907379
[TBL] [Abstract][Full Text] [Related]
3. AMPK Activation of Apoptotic Markers in Human Breast Cancer Cell Lines with Different p53 Backgrounds: MCF-7, MDA-MB-231 and T47D Cells.
El-Masry OS; Brown BL; Dobson PRM
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3763-3770. PubMed ID: 31870119
[TBL] [Abstract][Full Text] [Related]
4. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
5. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
[TBL] [Abstract][Full Text] [Related]
6. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic effects of α-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis.
Santha S; Bommareddy A; Rule B; Guillermo R; Kaushik RS; Young A; Dwivedi C
PLoS One; 2013; 8(2):e56982. PubMed ID: 23451128
[TBL] [Abstract][Full Text] [Related]
8. The PI3K/mTOR dual inhibitor NVP-BEZ235 stimulates mutant p53 degradation to exert anti-tumor effects on triple-negative breast cancer cells.
Cai J; Xia J; Zou J; Wang Q; Ma Q; Sun R; Liao H; Xu L; Wang D; Guo X
FEBS Open Bio; 2020 Apr; 10(4):535-545. PubMed ID: 32027103
[TBL] [Abstract][Full Text] [Related]
9. Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.
Hashemi M; Karami-Tehrani F; Ghavami S; Maddika S; Los M
Cell Prolif; 2005 Oct; 38(5):269-85. PubMed ID: 16202036
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of autophagy stimulate molecular iodine-induced apoptosis in hormone independent breast tumors.
Singh P; Godbole M; Rao G; Annarao S; Mitra K; Roy R; Ingle A; Agarwal G; Tiwari S
Biochem Biophys Res Commun; 2011 Nov; 415(1):181-6. PubMed ID: 22027149
[TBL] [Abstract][Full Text] [Related]
11. The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines.
De Santi M; Galluzzi L; Lucarini S; Paoletti MF; Fraternale A; Duranti A; De Marco C; Fanelli M; Zaffaroni N; Brandi G; Magnani M
Breast Cancer Res; 2011 Mar; 13(2):R33. PubMed ID: 21435243
[TBL] [Abstract][Full Text] [Related]
12. A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.
Brekman A; Singh KE; Polotskaia A; Kundu N; Bargonetti J
Breast Cancer Res; 2011 Jan; 13(1):R3. PubMed ID: 21223569
[TBL] [Abstract][Full Text] [Related]
13. ATP directed agent, 8-chloro-adenosine, induces AMP activated protein kinase activity, leading to autophagic cell death in breast cancer cells.
Stellrecht CM; Vangapandu HV; Le XF; Mao W; Shentu S
J Hematol Oncol; 2014 Mar; 7():23. PubMed ID: 24628795
[TBL] [Abstract][Full Text] [Related]
14. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
[TBL] [Abstract][Full Text] [Related]
15. Hypericin Induces Apoptosis in MDA-MB-175-VII Cells in Lower Dose Compared to MDA-MB-231.
Abbasi Gamasaee N; Radmansouri M; Ghiasvand S; Shahriari F; Zare Marzouni H; Aryan H; Jangholi E; Javidi MA
Arch Iran Med; 2018 Sep; 21(9):387-392. PubMed ID: 30221528
[TBL] [Abstract][Full Text] [Related]
16. Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53.
Ho TF; Ma CJ; Lu CH; Tsai YT; Wei YH; Chang JS; Lai JK; Cheuh PJ; Yeh CT; Tang PC; Tsai Chang J; Ko JL; Liu FS; Yen HE; Chang CC
Toxicol Appl Pharmacol; 2007 Dec; 225(3):318-28. PubMed ID: 17881028
[TBL] [Abstract][Full Text] [Related]
17. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
[TBL] [Abstract][Full Text] [Related]
18. Induction of Fas-mediated extrinsic apoptosis, p21WAF1-related G2/M cell cycle arrest and ROS generation by costunolide in estrogen receptor-negative breast cancer cells, MDA-MB-231.
Choi YK; Seo HS; Choi HS; Choi HS; Kim SR; Shin YC; Ko SG
Mol Cell Biochem; 2012 Apr; 363(1-2):119-28. PubMed ID: 22147197
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK.
Koyuturk M; Ersoz M; Altiok N
Cancer Lett; 2007 Jun; 250(2):220-8. PubMed ID: 17125918
[TBL] [Abstract][Full Text] [Related]
20. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]